RL

Ryan Lo

Vice President, Corporate Strategy & Business Development

Amaran Biotech

Therapeutic Areas

Amaran Biotech Pipeline

DrugIndicationPhase
AB-801Vaccine adjuvant (enhances immunogenicity)N/A